# US 2004/0082016 A1 · Antibodies specific for papillary fibroblasts as markers for skin quality

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0082016 A1
- Document ID: US20040082016A1
- Status: Published application
- Kind: A1
- Application number: 10/619,188
- Filed: 2003-07-15
- Published: 2004-04-29
- Earliest claimed: 1999-12-03
- Assignees: L'oreal
- Inventors: Daniel Asselineau; Arnold Caplan
- Web page: https://patentgrep.com/patent/US20040082016A1

## CPC

- G01N 33/6881: {from skin}
- G01N 2400/40: Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides
- G01N 2800/20: Dermatological disorders
- Y10S 435/971: Capture of complex after antigen-antibody reaction
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

## Abstract

Whether or not a sample of skin or of a skin equivalent contains such amount of a papillary fibroblast population as to be considered a normal skin is determined by labelling said skin or skin equivalent with at least one antibody specific for papillary fibroblasts and evaluating the extent of such labelling as a marker for skin or skin equivalent quality.

## Claims

### Claim 1

A regime for determining whether or not a sample of skin or of a skin equivalent contains such amount of a papillary fibroblast population as to be considered a normal skin, comprising labelling said skin or skin equivalent with at least one antibody specific for papillary fibroblasts and evaluating the extent of such labelling as a marker for skin or skin equivalent quality.

### Claim 2 (depends on 1)

The determinative regime as defined by claim 1, said at least one antibody comprising a monoclonal antibody.

### Claim 3 (depends on 1)

The determinative regime as defined by claim 1, said at least one antibody comprising a horse, goat, mouse, rat or rabbit antibody.

### Claim 4 (depends on 3)

The determinative regime as defined by claim 3, said at least one antibody comprising a mouse antibody.

### Claim 5 (depends on 1)

The determinative regime as defined by claim 1, said at least one antibody comprising the PG4 antibody.

### Claim 6 (depends on 1)

The determinative regime as defined by claim 1, comprising immunolabelling said skin or skin equivalent with at least one antibody specific for papillary fibroblasts.

### Claim 7

A regime for determining the presence of papillary fibroblasts in a given sample, comprising labelling said sample with at least one antibody specific for papillary fibroblasts and evaluating the intensity of any such labelling as a marker for the presence of said papillary fibroblasts.

### Claim 8 (depends on 7)

The determinative regime as defined by claim 7, said at least one antibody comprising the PG4 monoclonal antibody.
